Novo Nordisk A/S Common Stock (NVO) Cost of Revenue & History | Stock Alarm

Demo Sign up Log In

Novo Nordisk A/S Common Stock · Cost of Revenue

NVO Cost of Revenue

Latest reportedkr 63.75B DKKperiod endingJun 30, 2026

NVO Cost of Revenue · DKK (kr 2.07B → kr 63.75B)

Annual cost of revenue

High-resolution chart · PNG

NVO cost of revenue history

Annual fiscal periods · DKK. Dates are reporting period ends; fiscal years can differ from calendar years.

Novo Nordisk A/S Common Stock Cost of Revenue — Annual fiscal periods (DKK)
Period ending	Cost of Revenue (DKK)
Dec 31, 2025	58,788,000,000
Dec 31, 2024	44,522,000,000
Dec 31, 2023	35,765,000,000
Dec 31, 2022	28,448,000,000
Dec 31, 2021	23,658,000,000
Dec 31, 2020	20,932,000,000
Dec 31, 2019	20,088,000,000
Dec 31, 2018	17,617,000,000
Dec 31, 2017	17,632,000,000
Dec 31, 2016	17,183,000,000
Dec 31, 2015	16,188,000,000
Dec 31, 2014	14,562,000,000
Dec 31, 2013	14,140,000,000
Dec 31, 2012	13,465,000,000
Dec 31, 2011	12,589,000,000
Dec 31, 2010	11,680,000,000
Dec 31, 2009	10,438,000,000
Dec 31, 2008	10,131,385,000
Dec 31, 2007	9,803,538,000
Dec 31, 2006	9,589,068,000
Dec 31, 2005	9,165,987,000
Dec 31, 2004	8,105,495,000
Dec 31, 2003	7,461,827,000
Dec 31, 2002	6,624,718,000
Dec 31, 2001	5,964,763,000
Dec 31, 2000	4,379,575,000
Dec 31, 1999	3,629,968,000
Dec 31, 1998	3,216,355,000
Dec 31, 1997	4,721,705,000
Dec 31, 1996	4,167,384,000
Dec 31, 1995	3,829,522,000
Dec 31, 1994	3,833,399,000
Dec 31, 1993	6,407,685,000
Dec 31, 1992	2,526,563,000
Dec 31, 1991	4,795,257,150
Dec 31, 1990	4,125,219,200
Dec 31, 1989	3,764,953,500
Dec 31, 1988	2,716,604,800
Dec 31, 1987	2,589,793,200
Dec 31, 1986	3,293,845,500
Dec 31, 1985	2,073,373,200

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.